What's new

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised

Mar 17, 2025 - 13:42
 0
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 64, Status: Authorised
Read More

Tags:

Previous Article

Workshop managers share concerns over potential MOT recall rule change

Next Article

Health Canada approves RetinaLogik’s VR visual exam platform

Related Posts

Records of data processing activity regarding the proce...

Feb 14, 2025  0

PSUSA/00000434/202407

PSUSA/00000434/202407

Feb 19, 2025  0

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - March 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 25 March 2025, 11:00 (CET) to 25 March 2025, 12:00 (CET)

Questions and answers clinic on Product Management Serv...

Mar 7, 2025  0